Why is Astec Lifescienc falling/rising?

As of 02-Sep, Astec Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 854.25, which reflects a decrease of Rs 9.75 or 1.13%. The stock has underperformed its sector by 0.83% today and has been on a downward trend for the last two days, accumulating a total loss of 2.85%. Over the past week, the stock has shown a slight gain of 0.15%, but it has significantly underperformed over longer periods, with a year-to-date decline of 15% and a staggering 28.87% drop over the past year. The company has faced operating losses and has reported negative results for the last five consecutive quarters, contributing to its weak long-term fundamental strength. Additionally, a high Debt to EBITDA ratio of 2.64 times and a negative EBITDA further indicate financial instability, which negatively impacts investor confidence.
In the broader market context, while the Sensex has shown a slight decline of 0.55% over the past month, Astec Lifesciences Ltd's performance has been notably worse, with a 3.10% drop in the same period. The stock's consistent underperformance against the benchmark over the last three years, coupled with a significant fall in profitability, has raised concerns among investors. The delivery volume has also decreased by 38.2% against the five-day average, suggesting a lack of investor participation. Overall, the combination of negative financial indicators and poor market performance has led to a declining stock price for Astec Lifesciences Ltd.